S&P 500

5.361,06

0,15%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Neonmind Biosciences Inc (PK) (NMDBF)
Neonmind Biosciences Inc (PK) (NMDBF) Notícias

NMDBF

Neonmind Biosciences (PK) (NMDBF)

Neonmind Biosciences Inc (PK)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:NMDBF

1

Data	Hora	Fonte	Título	Código	Companhia
28/09/2021	07:45	InvestorsHub NewsWire	NeonMind Advances Strategy for Specialty Clinic Launch	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
22/09/2021	07:30	InvestorsHub NewsWire	NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
16/09/2021	12:39	InvestorsHub NewsWire	NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
08/09/2021	07:31	InvestorsHub NewsWire	NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
28/07/2021	08:03	InvestorsHub NewsWire	Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
29/06/2021	09:50	InvestorsHub NewsWire	NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
10/06/2021	08:57	InvestorsHub NewsWire	NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
28/05/2021	09:24	InvestorsHub NewsWire	NeonMind to Commence Trading on the OTCQB Venture Market	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
06/04/2021	09:10	InvestorsHub NewsWire	NeonMind Developing Music Playlist for Psychedelic Therapy Sessions	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
09/03/2021	10:00	InvestorsHub NewsWire	NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity	USOTC:NMDBF	Neonmind Biosciences Inc (PK)